U.S. Supreme Court Won’t Rule Whether Off-Label Drug Warnings Are Preempted

Mealey's (May 17, 2021, 2:16 PM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court on May 17 denied a petition by Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. to review Pennsylvania state court rulings that drug maker defendants...
To view the full article, register now.